Ticker Details
Marker Therapeutics, Inc.
IPO Date:	August 1, 2002
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$29.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 4.34%
Avg Daily Range (30 D):	$0.05 | 3.35%
Avg Daily Range (90 D):	$0.07 | 4.30%

Institutional Daily Volume
Avg Daily Volume:	.22M
Avg Daily Volume (30 D):	.12M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	127
Avg Trade Size (Sh.) (30 D):	183
Avg Trade Size (Sh.) (90 D):	288

Institutional Trades
Total Institutional Trades:	24
Avg Institutional Trade:	$2.18M
Avg Institutional Trade (30 D):	$.92M
Avg Institutional Trade (90 D):	$.92M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.02M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	106.23K

News

Aug 28, 2025 @ 12:00 PM Marker Therapeutics to Participate in a Fireside C... Source: Marker Therapeutics, Inc.

Aug 26, 2025 @ 11:00 AM Marker Therapeutics Provides Update on Phase 1 APO... Source: Marker Therapeutics

Jun 17, 2025 @ 12:00 PM Marker Therapeutics and Cellipont Bioservices Anno... Source: N/A

Nov 26, 2024 @ 4:00 PM Marker Therapeutics to Present at the Citizens JMP... Source: N/A

May 15, 2024 @ 8:15 PM Marker Therapeutics Reports First Quarter 2024 Fin... Source: Marker Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.79	$-.04	$-.79
Diluted EPS	$-.79	$-.04	$-.79
Revenue	$3.55M	$1.1M	$3.55M
Gross Profit
Net Income / Loss	$-12.16M	$-1.7M	$-12.16M
Operating Income / Loss	$-12.89M	$-1.88M	$-12.89M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Jan 27, 2023	1:10
Sep 16, 2016	1:12
Feb 25, 2014	1:100
Jul 27, 2009	1:10
Jun 28, 2007	2:5
Jun 08, 2001	1:50